Clinical Application of Propofol Remifentanial Anesthesis with Laryngeal Mask Airway Ventilation in Old Operative Patients
Wen Xue-fe
Abstract
Wen Xue-fe
Abstract
Objective: To investigate the clinical application effect of target-controlled infusion with propofol remifentanil anesthesia with laryngeal mask airway ventilation in old operative patients. Methods: 127 old operative patients were chosen as research objects. They were randomly divided into A, B and C group. A group: propofol remifentanial anesthesia with laryngeal mask airway ventilation(n=43). B group: propofol anesthesia with laryngeal mask airway(n=42). C group: propofol remifentanial anesthesia with face mask airway ventilation(n=42). Anesthesia was induced by target controlled infusion. Anesthesia induction time, intraoperative reaction,anesthetic effect, sedative effect score, recovery time, recovery quality and incidence of side effect were observed. Results: The dosage of propofol:(335.2±56.4)mg in A group,(466.5±64.8)mg in B group(,334.8±59.7)mg in C group. The difference was statistically significant by analysis of variance(F=6.513, P0.05). Ramsay score: The cases of 6 points were respectively 37 cases(86.0%), 30 cases(71.4%) and 32 cases(81.0%) in A, B and C group. There was significant difference by Chi square(X2=5.832, P0.05). Incidence of side effect: 5 cases(11.6%)in A group,15 cases(35.7%)in B group, 7 cases(16.7%)in C group. There was significant difference by Chi square(X2=7.546, P0.05). Conclusions: The effect of propofol remifentanil anesthesia with laryngeal mask airway ventilation in old operative patients is remarkable. It is safe and effective.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the clinical application effect of target-controlled infusion with propofol remifentanil anesthesia with laryngeal mask airway ventilation in old operative patients. Methods: 127 old operative patients were chosen as research objects. They were randomly divided into A, B and C group. A group: propofol remifentanial anesthesia with laryngeal mask airway ventilation(n=43). B group: propofol anesthesia with laryngeal mask airway(n=42). C group: propofol remifentanial anesthesia with face mask airway ventilation(n=42). Anesthesia was induced by target controlled infusion. Anesthesia induction time, intraoperative reaction,anesthetic effect, sedative effect score, recovery time, recovery quality and incidence of side effect were observed. Results: The dosage of propofol:(335.2±56.4)mg in A group,(466.5±64.8)mg in B group(,334.8±59.7)mg in C group. The difference was statistically significant by analysis of variance(F=6.513, P0.05). Ramsay score: The cases of 6 points were respectively 37 cases(86.0%), 30 cases(71.4%) and 32 cases(81.0%) in A, B and C group. There was significant difference by Chi square(X2=5.832, P0.05). Incidence of side effect: 5 cases(11.6%)in A group,15 cases(35.7%)in B group, 7 cases(16.7%)in C group. There was significant difference by Chi square(X2=7.546, P0.05). Conclusions: The effect of propofol remifentanil anesthesia with laryngeal mask airway ventilation in old operative patients is remarkable. It is safe and effective.
Key concepts: Propofol, Medicine, Anesthesia, Remifentanil, Laryngeal mask airway, Airway, Ventilation (architecture), Anesthetic